Skip to main
DBD

DBD Stock Forecast & Price Target

DBD Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Diebold Nixdorf is expected to experience strong financial performance in the future, thanks to robust demand for their products in key markets and strategic operational improvements. With a solid balance sheet and plans for increased buybacks, there is potential for a re-rating and attractive free cash flow yields. Despite some risks, analysts are optimistic about the company's prospects and have raised their price target to $100, with a projected EPS of $80 for 2027.

Bears say

Diebold Nixdorf is benefiting from their domestic factory and lean practices leading to significant growth potential and partnerships with major retailers in both general merchandise and grocery segments. Additionally, their undemanding valuation, lower leverage compared to its closest peer, and consistent FCF generation through share buybacks indicate a positive outlook. Lastly, potential tailwinds from lower operating expenses, declining tax rates, and possibly lower interest expenses further support a positive outlook for the company.

DBD has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Diebold Nixdorf Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Diebold Nixdorf Inc (DBD) Forecast

Analysts have given DBD a Buy based on their latest research and market trends.

According to 2 analysts, DBD has a Buy consensus rating as of May 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $100, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $100, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Diebold Nixdorf Inc (DBD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.